New diabetes clinical trial: A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin

Published on: February 28, 2018 at 10:30PM
Conditions:   Cardiovascular Diseases;   Type 2 Diabetes Mellitus
Interventions:   Drug: Apelin;   Drug: Relaxin;   Drug: Normal saline;   Diagnostic Test: Verapamil;   Diagnostic Test: LN Monomethyl arginine
Sponsors:   Cambridge University Hospitals NHS Foundation Trust;   University of Cambridge;   AstraZeneca;   MedImmune LLC
Not yet recruiting
http://ift.tt/2oBEvI6